Dietary Recommendations for Chronic Kidney Disease
For patients with CKD stages 3-5 not on dialysis, prescribe a low-protein diet of 0.55-0.60 g/kg/day under close supervision, combined with energy intake of 25-35 kcal/kg/day and sodium restriction to less than 2 g/day (5 g salt), while ensuring adequate nutritional monitoring to prevent malnutrition. 1
Protein Intake: The Core Intervention
The protein prescription varies dramatically by CKD stage and dialysis status:
For Non-Dialysis CKD Patients (Stages 3-5)
Without diabetes: Implement protein restriction of 0.55-0.60 g/kg/day, or alternatively a very low-protein diet of 0.28-0.43 g/kg/day supplemented with keto acid analogs to meet total requirements of 0.55-0.60 g/kg/day. This approach reduces risk of end-stage kidney disease and death (grade 1A evidence) 1. The 2025 guidelines reinforce that this can be safely implemented when energy intake exceeds 30 kcal/kg/day, and does not lead to malnutrition under adequate supervision 2.
With diabetes: Target 0.6-0.8 g/kg/day to maintain nutritional status while optimizing glycemic control 1, 2. This slightly higher range accounts for the metabolic demands and glycemic variability in diabetic patients.
Critical caveat: The average Western protein consumption is approximately 1.3 g/kg/day, meaning most patients will need to reduce intake by 40-50% 2. This requires intensive dietary counseling with a registered dietitian nutritionist.
For Dialysis Patients (Stage 5D)
Reverse the restriction completely: Prescribe 1.0-1.2 g/kg/day for both hemodialysis and peritoneal dialysis patients to maintain stable nutritional status and compensate for dialysis-related protein losses 1. Diabetic dialysis patients may require higher protein intake to maintain glycemic control.
Energy Requirements
Prescribe 25-35 kcal/kg/day based on age, sex, physical activity level, body composition, and presence of inflammation 1. Adequate energy intake is essential—without it, protein restriction leads to muscle catabolism and malnutrition. The 2025 evidence emphasizes that energy intake above 30 kcal/kg/day prevents malnutrition during protein restriction 2.
Sodium Restriction
Limit sodium to less than 2 g/day (equivalent to 5 g salt/day) 3, 4. This is critical for blood pressure control and reducing CKD progression. More than half of CKD patients exceed this limit in real-world practice 5, making this a high-yield intervention target.
Potassium Management
Individualize potassium intake to maintain serum levels within normal range (below 5 mmol/L) 6, 4. For patients with eGFR <30 mL/min/1.73 m², potassium restriction becomes necessary. However, avoid blanket restrictions in earlier stages, as low potassium associates with muscle weakness and hypertension.
Phosphorus Control
Limit phosphorus to maximum 1 g/day to prevent hyperphosphatemia and bone mineral disease 6. This naturally occurs with protein restriction, as high-protein foods are typically high in phosphorus.
Dietary Pattern Recommendations
Mediterranean diet: Suggested for CKD stages 1-5 not on dialysis to improve lipid profiles (grade 2C) 1. This pattern naturally aligns with protein restriction while providing cardiovascular benefits.
Increased fruits and vegetables: For CKD stages 1-4, this decreases body weight, blood pressure, and net acid production 1. Plant-based proteins may offer advantages over animal proteins, though evidence remains insufficient to mandate one over the other 1.
Monitoring and Supervision Requirements
Essential monitoring parameters:
- Appetite and dietary intake patterns
- Body weight changes (watch for unintentional loss)
- Biochemical markers: BUN, albumin, prealbumin
- Anthropometric measurements
- Nutrition-focused physical findings 1
Critical pitfall: Protein restriction without adequate energy intake and monitoring leads to protein-energy wasting. Patients with DM show higher protein intake and BUN levels in practice 5, requiring more intensive counseling.
When Dietary Counseling Fails
If dietary counseling alone does not achieve adequate energy and protein intake, initiate a minimum 3-month trial of oral nutritional supplements for patients at risk of or with protein-energy wasting 1. This applies to CKD stages 3-5D and post-transplant patients.
Medical Nutrition Therapy Structure
All dietary interventions should be delivered by a registered dietitian nutritionist in close collaboration with the physician, tailored to individual needs, nutritional status, and comorbid conditions 1. This is not optional—the complexity of balancing protein restriction, adequate energy, electrolyte management, and malnutrition prevention requires specialized expertise.